Poliwogg News

3 Reasons To Like This Small-Cap Biotech ETF

Sector-focused ETFs can be high-risk, high-reward plays. ALPS Medical Breakthroughs (SBIO) tanked 13% during the big August sell-off and has since re-bounded 6%. Broadly diversified peers saw smaller losses last month and are recovering nicely too. The risk-for-reward proposition is especially acute with biotechnology exchange traded funds and even more so for small-caps. SBIO, a smaller-cap biotech ETF, is the...

Read More

Poliwogg In the News